This study investigates the proteomic landscape of ferroptosis, a type of cell death characterized by lipid peroxidation and iron dependency. Through proteomic analysis, the researchers identified choline/ethanolamine phosphotransferase 1 (CEPT1) as an interacting partner of lysophosphatidylcholine acyltransferase 3 (LPCAT3), crucial for maintaining LPCAT3 protein stability. Contrary to its known role in phospholipid synthesis, CEPT1 was found to suppress ferroptosis by interacting with phospholipases and breaking down pro-ferroptotic polyunsaturated fatty acid (PUFA)-containing phospholipids. This discovery highlights a novel function of CEPT1 in the regulation of ferroptosis.

A research group led by Associate Professor Ayako Okado-Matsumoto from the Department of Biology at Toho University, in collaboration with Professor Ryuji Sakakibara (at the time of the study) from the Department of Neurology at Toho University Medical Center Sakura Hospital, discovered that the formation of mitochondrial respiratory chain supercomplexes, encompassing energy production-related enzymes, in the peripheral blood leukocytes of patients with neurodegenerative diseases (such as Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies) correlates with disease progression.

The continuous advancement of single-cell technologies promises to further enhance our understanding of liver biology. Emerging techniques, such as single-cell multiomics and spatially resolved transcriptomics, offer even greater resolution and integration of cellular data. These advancements are expected to drive the development of more precise and personalized therapeutic strategies for liver diseases.